 | Nepafenac | CAS #:78281-72-8 |
| | Eta reagent | Tel:+86 021-58055199 More |
|
| N4-Benzoylcytosine | CAS #:26661-13-2 |
| | Jiangsu Jintan Kangyuan Chemical Co., Ltd | Tel:86-519-82566282/82566295 More |
|
| Methyl 4-bromo-1H-pyrrole-2-carboxylate | CAS #:934-05-4 |
| | Suzhou xinkai bio-medical technology co., ltd. | Tel:+86-0512-82216625 More |
|
| 1,4-Diiodo-2,5-dimethylbenzene | CAS #:1124-08-9 |
| | Suzhou xinkai bio-medical technology co., ltd. | Tel:+86-0512-82216625 More |
|
| 1-Benzyl-4-(Chloromethyl)-1H-Pyrazole Hydrochloride | CAS #:861135-54-8 |
| | Suzhou xinkai bio-medical technology co., ltd. | Tel:+86-0512-82216625 More |
|
| 5-(2-Fluorophenyl)-1H-pyrrole-3-carbaldehyde | CAS #:881674-56-2 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 3-(tert-Butyl)-2-hydroxybenzaldehyde | CAS #:24623-65-2 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| (2R)-2-methyl-1-[(2-methylpropan-2-yl)oxycarbonyl]pyrrolidine-2-carboxylic acid | CAS #:166170-15-6 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 2-(4-(Hydroxymethyl)phenyl)acetic acid | CAS #:73401-74-8 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| methyl 2-[4-(hydroxymethyl)phenyl]acetate | CAS #:155380-11-3 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 4-chlorobutanol | CAS #:928-51-8 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 2-chloro-1-(1-chlorocyclopropyl)ethanone | CAS #:120983-72-4 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 7-bromo-3,4-dihydro-1H-naphthalen-2-one | CAS #:132095-54-6 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 2-Amino-5-bromo-3-iodopyridine | CAS #:381233-96-1 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
| 1-(3-Pyridyl)-3-(dimethylamino)-2-propen-1-one | CAS #:55314-16-4 |
| | Tianjin hexinde biotechnology co.,ltd. | Tel:0086-22-83965054 More |
|
